PET-MRI에 대한 최적의 정보 제공에 대한 연구: 문헌 보고 중심으로
A Study on the Optimal Information Provision for PET-MRI: Focused on Literature Article
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Currently, state-of-the-art devices such as SPECT, PET/CT, and PET/MRI are rapidlyspreading nationwide, and the penetration rate of nuclear medical devices is also ranked fifth in theworld. However, PET/MRI’s system is slower and less common because it is more complex than PET/CT. The purpose of this study is to provide optimal information on PET/MRI according to the patient’s disease. The subjects obtained information on head and neck cancer, pediatric patients, breast cancer patients,heart disease patients, lung cancer patients, and rectal cancer patients. We tried to accumulate protocolsby obtaining a lot of information about each disease. In diagnosing head and neck cancer, it is believed thatit is highly likely to be used in evaluating preoperative stage determination, recurrence and remote metastasisafter treatment, and unclear primary cervical lymph node metastasis. Diagnosis and continuousfollow-up of pediatric patients can increase patient benefits by minimizing radiation exposure. Breastcancer provides a comprehensive evaluation of the clinical need to determine the extent of disease inbreast and local lymph nodes and the systematic stages of early diagnosis or recurrence. In diagnosingheart disease patients, MR-based PET motion correction helps to realize the full potential of PET images. For lung cancer patients, the clinical value and usefulness of the resolution and detection ability ofintegrated PET/MRI for soft tissues such as lung cancer will be sufficient. In diagnosing rectal cancerpatients, the detection of missing residual diseases can change the clinical response evaluation forrectal cancer patients treated with TNT, and both the initial stage and treatment response evaluation arepossible. Therefore, this literature study provided basic clinical data for PET/MRI tests.
Abstract
Currently, state-of-the-art devices such as SPECT, PET/CT, and PET/MRI are rapidlyspreading nationwide, and the penetration rate of nuclear medical devices is also ranked fifth in theworld. However, PET/MRI’s system is slower and less common because it is more complex than PET/CT. The purpose of this study is to provide optimal information on PET/MRI according to the patient’s disease. The subjects obtained information on head and neck cancer, pediatric patients, breast cancer patients,heart disease patients, lung cancer patients, and rectal cancer patients. We tried to accumulate protocolsby obtaining a lot of information about each disease. In diagnosing head and neck cancer, it is believed thatit is highly likely to be used in evaluating preoperative stage determination, recurrence and remote metastasisafter treatment, and unclear primary cervical lymph node metastasis. Diagnosis and continuousfollow-up of pediatric patients can increase patient benefits by minimizing radiation exposure. Breastcancer provides a comprehensive evaluation of the clinical need to determine the extent of disease inbreast and local lymph nodes and the systematic stages of early diagnosis or recurrence. In diagnosingheart disease patients, MR-based PET motion correction helps to realize the full potential of PET images. For lung cancer patients, the clinical value and usefulness of the resolution and detection ability ofintegrated PET/MRI for soft tissues such as lung cancer will be sufficient. In diagnosing rectal cancerpatients, the detection of missing residual diseases can change the clinical response evaluation forrectal cancer patients treated with TNT, and both the initial stage and treatment response evaluation arepossible. Therefore, this literature study provided basic clinical data for PET/MRI tests.
참고문헌 (18)
- Stefan Adams, "Prospective comparison of 18 F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer", European Journal of Nuclear Medicine and Molecular Imaging, 25(9), pp.1255~1260 (1998), Springer Science and Business Media LLC[DOI]
- Denys J. Loeffelbein, "PET-MRI Fusion in Head-and-Neck Oncology: Current Status and Implications for Hybrid PET", MRI, 2012, pp.70(2), 473~483[DOI]
- Castelijns JA, "PET-MRI in the head and neck area : challenges and new directions", Eur. Radiol, 21(11), pp.2425~2426 (2011)[DOI]
- Kim Jl, "Comparison of SUV for PET", MRI and PET, KJMNT, pp.2013, 17(2)[DOI]
- Kim KM, "One-stop Evaluation Protocol of Ischemic Heart Disease : Myocardial Fusion PET Study", KJMNT, 14(2), pp.33~37 (2010)
- 나영신, "뇌혈관질환에서 SPECT와 PET의 임상적 응용", Nuclear Medicine and Molecular Imaging, 37(1), pp.1~12 (2003), 대한핵의학회
- 박철수, "핵의학(Nuclear Medicine) 소개 PET", MRI, 2019, pp.29(5), 184~195[DOI]
- Laubenbacher C, "Comparison of 18F-FDG PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas", J. Nucl. Med, 36(10), pp.1747~1757 (1995)
- Braams JW, "Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI", J. Nucl. Med, 36(2), pp.211~216 (1995)
- Platzek I, "PET", MRI in head and neck cancer : initial experience, 2013, pp.40(1), 6~11
- Stephen MB, "Clinical PET", MRI : 2018 Update : Review, 2018, pp.211(2), 295~313
- Schramm G, "Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET", MR system : a direct comparison with transmission-based attenuation correction, 2013, pp.26(1), 115~126
- Kraus R, "Simulation Study of Tissue-Specific Positron Range Correction for the New Biograph mMR Whole-Body PET", MR System, 2012, pp.59(5), 1900~1909
- Feng J, "Design of a shielded coil element of a matrix gradient coil", J. Magn. Reson, 281, pp.217~228 (2017)[DOI]
- 이재헌, "시간 경과에 따른 자기장 노출 유·무 환경에서 열형광선량계의 글로우 곡선 및 피폭 방사선량 분석", 한국콘텐츠학회 논문지, 16(8), pp.419~426 (2016), 한국콘텐츠학회[DOI]
- Claudio S, "18F-FDG PET", CT and PET, J. Nucl. Med, pp.2016, 57(3)[DOI]
- Gerard SK, "PET", MRI Versus PET, J. Nucl. Med, pp.2021, 62(4)[DOI]
- Mannheim JG, "PET", MRI Hybrid Systems, 2018, pp.48(4), 332~347